Compugen Ltd
NASDAQ:CGEN
Compugen Ltd
Cash Equivalents
Compugen Ltd
Cash Equivalents Peer Comparison
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Compugen Ltd
NASDAQ:CGEN
|
Cash Equivalents
$13.9m
|
CAGR 3-Years
25%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
Q
|
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
|
Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
B
|
Biolight Life Sciences Ltd
TASE:BOLT
|
Cash Equivalents
₪5.3m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
-11%
|
See Also
What is Compugen Ltd's Cash Equivalents?
Cash Equivalents
13.9m
USD
Based on the financial report for Dec 31, 2023, Compugen Ltd's Cash Equivalents amounts to 13.9m USD.
What is Compugen Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
19%
Over the last year, the Cash Equivalents growth was 25%. The average annual Cash Equivalents growth rates for Compugen Ltd have been 25% over the past three years , 19% over the past five years .